Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
Group Parameters
Patient‐related

Age

Gender

BMI

HCT‐CI

Charlson CI

Previous thrombotic history

Number of thromboembolic events

Thrombotic complications on initial therapy of MM

Disease‐related

M protein type

Stage D‐S, ISS, R‐ISS

Bone disease

Kidney insufficiency before ASCT

Catheter‐related

Location

Time from placement to removal

Treatment‐related

Conditioning type (myeloablative/non‐myeloablative)

Complications:
  • Infectious/Non‐infectious
  • CVC infection
  • CVS complications/GI complications